-
2024 expectations for Wegovy, Ozempic, Zepbound
George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed insurance coverage and a handful of unpleasant side effects. …
-
Elliott Wilson Apologizes To Kai Cenat After Nicki Minaj Dispute
Elliott Wilson has issued a public apology to Twitch streamer Kai Cenat after feeling some type of way about his interview with Nicki Minaj earlier this week. The hip hop journalist had previously interviewed the rapper when she dropped her 2014 album, ‘The Pinkprint,’ and again in 2018, following the release of ‘Queen.’ But amid…
-
Activision Blizzard agrees to settle California intercourse discrimination case
Activision Blizzard CEO Bobby Kotick speaks at the CNBC Evolve conference November 19th in Los Angeles. Jesse Grant | CNBC Microsoft-owned Activision Blizzard has agreed to settle a case from a California state agency that alleged the video game publisher discriminated against women, including denying them promotion opportunities and paying them less. California’s Civil Rights…
-
Rudy Giuliani ordered to pay Georgia election employees for defamation
Rudy Giuliani at 60 Centre Street in Manhattan on Thursday, Sept. 8, 2022. Theodore Parisienne | Tribune News Service | Getty Images A federal jury on Friday ordered Rudy Giuliani to pay over $148 million to two Georgia election workers for falsely claiming they committed ballot fraud in the 2020 presidential election. The jaw-dropping figure…
-
Moderna, Merck most cancers vaccine reduces danger of pores and skin most cancers return
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three years, according to midstage…
-
IRS rejects 20,000 tax refund claims for worker retention credit score
IRS Commissioner Daniel Werfel speaks during an IRS event on August 2, 2023 in McLean, Virginia. Alex Wong | Getty Images The IRS is sending more than 20,000 rejection letters to taxpayers who wrongly claimed a pandemic-era tax break as the agency continues its crackdown on “dubious” filings. Created to support small businesses during the…
-
Potential Trump 2024 Faux Electors Will not Take part As a result of They Are Scared Of Going To Jail
Arrests and criminal prosecutions are proving to be an effective way of deterring Republicans from participating in a potential Trump attack on the 2024 election. The Washington Post reported: In the past few months, 25 of those 84 electors have been charged with felonies, such as forgery, false statements, and filing false documents. Ten more…
-
15 Issues You Ought to Pack To Keep away from Checking a Bag on the Airport
We independently selected these products because we love them, and we think you might like them at these prices. E! has affiliate relationships, so we may get a commission if you purchase something through our links. Items are sold by the retailer, not E!. Prices are accurate as of publish time. Does anyone actually enjoy…
-
Elon Musk reactivates Alex Jones’ X account
C.E.O. of Tesla, Chief Engineer of SpaceX and C.T.O. of X Elon Musk takes the stage during the New York Times annual DealBook summit on November 29, 2023 in New York City. Michael M. Santiago | Getty Images Elon Musk on Sunday reinstated the account of conspiracy theorist Alex Jones on X, formerly Twitter, reneging…
-
First CRISPR gene-editing remedy authorized in U.S.
The U.S. Food and Drug Administration on Friday approved the country’s first gene-editing treatment, Casgevy, for use in patients with sickle cell disease. The approval comes about a decade after the discovery of CRISPR technology for editing human DNA, representing a significant scientific advancement. Yet reaching the tens of thousands of people who could benefit…
